[IMRX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[IMRX] Immuneering Corporation
Announcement Date
10-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 10.41%
YoY- -44.30%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 0 0 38 94 184 190 482 -
PBT -13,604 -13,246 -12,844 -11,527 -12,897 -11,092 -8,534 36.50%
Tax -1,075,403 -740 -344 -52 -29 -307 -17 159735.75%
NP 1,061,799 -12,506 -12,501 -11,527 -12,867 -10,784 -8,534 -
Tax Rate - - - - - - - -
Total Cost -1,061,799 12,506 12,539 11,622 13,051 10,974 9,016 -
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin 0.00 -2,742,434.65 -32,570.38 -12,208.67 -7,004.48 -5,688.22 -1,770.08 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 -0.47 -
EPS Diluted 40.16 -0.47 -0.47 -0.44 -0.49 -0.42 -0.47 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.